Open in interactive viewer → charts, metric popovers & call review

i-80 Gold Delivers on Recap, Pivots to Execution — Oxide Discovery at Archimedes Adds Fuel

Post-recapitalization i-80 turns to development milestones, while a high-grade oxide find at Archimedes could accelerate cash flows before Lone Tree's 2027 restart.
IAUX · Earnings Call · 2026-08-11

From Survival to Execution

i-80 Gold's second-quarter 2026 report marks a clear inflection point. Management's language has shifted from securing financing to delivering a multiphase development plan. After the Granite Creek Underground ramp and the recapitalization closed earlier this year, the company is now focused on converting its Nevada asset base into production. As CEO Richard Young put it, "Our focus remains on the factors we can control: Execution." The market is taking note — the stock is up 7.7% over the last 90 days, recovering from a 41% drawdown from its 2022 peak.

As we deliver these milestones, we believe we will close the valuation gap between our current market value and the underlying value of our asset base.

Richard S. Young, President and Chief Executive Officer (CEO) · 2026-08-11

Granite Creek Ramp and a Promising Oxide Discovery

At Granite Creek, the production story is on track despite temporary ground conditions that "restricted access and deferred a portion of high grade mining tonnes during Q2," according to COO Paul Chawrun. The mine is now ahead on development with roughly 15 working headings, and grades are expected to improve in Q3. Year-to-date output of 17.5k ounces positions the company to meet its 30–40k ounce guidance.

More intriguing is the high grade oxide mineralization discovered in the Upper 426 zone at Archimedes. Paul Chawrun noted during the call: "Drilling intersected significant high grade oxide mineralization that was not included in the mineral resource estimate that supported the 2025 PEA providing potential upside in the near term mine plan." This is a company-unique theme that has not appeared in prior calls — and it could add low-cost, near-term ounces ahead of the Lone Tree plant restart. The drilling campaign at Archimedes is slower than planned due to contractor staffing, pushing the feasibility study to mid-2027, but the oxide potential is a fresh catalyst.

Balance Sheet Strength and the Path to Lone Tree

Financially, the recapitalization is holding. Cash stands at $465 million, down from $514 million at the end of Q1 — in line with expectations as development spending ramps. Total revenue rose to $52 million in Q1 2026, a 273% year-over-year increase, although the $79 million net loss reflects non-cash mark-to-market on the new financial instruments plus predevelopment expenses. CFO Ryan Snow emphasized that these instruments are "carried at fair value, and are updated each reporting period to reflect changes in metals prices and discount rates."

Revenue is climbing steeply from near-nothing, but the predevelopment cost line - expensed under U.S. GAAP until reserves are declared - keeps the company loss-making for now.

The Lone Tree the Lone Tree plant refurbishment remains the centerpiece, on schedule for first gold by end-2027, with ~40% of committed capital already placed. The company is already planning to stockpile sulfide material from both Granite Creek and Archimedes to fill that plant in 2028. This is the transition from toll milling (at ~$275–280/t) to owner processing (saving $1,000–1,500/oz in cash margin) that management has been telegraphing for over a year.

Guidance and Key Catalysts

Management narrowed 2026 guidance: growth capex stays at $150–175 million (accrual), Lone Tree capex at the bottom end, Archimedes capex up $10–15 million for surface infrastructure, and exploration down $10 million on contractor delays. Investors should key on three near-term catalysts over the next 12 months: Archimedes first gold (Q4 2026), the feasibility studies on all three underground projects (Granite Creek in Q3 2026), and the Mineral Point prefeasibility study.

The Phase 1 development plan targets 150–200k ounces by 2028, and the oxide discovery at Archimedes could add even earlier cash flows. As Young said on the call: "These oxide drill results at Archimedes have the potential to make a meaningful difference to our production cash flows as early as next year." That is the line that matters.

Prior calls laid the groundwork: in February 2026, management described the autoclave refurbishment in detail, and in May 2025, they discussed the toll-milling arrangement and stockpiling oxide. But the oxide upside is new — and it is what makes this quarter's story more than a routine update.